Clinical Trials Directory

Trials / Completed

CompletedNCT05755347

Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer

Assessing Functional Status Needs Via Patient-Reported Outcomes Measures in the Pre-treatment Setting With Metastatic Breast Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The purpose of this single-site non-randomized study is to identify areas of need related to functional status and overall health, including nutrition and mental health in subjects with metastatic breast cancer (MBC). A decline in functional status is observed after breast cancer diagnosis and exacerbated by treatment. Declining functional status impacts the quality of life and can lead to increased comorbidity burden, hospitalization, and increased mortality. Functional status is assessed by specific provider-graded scales. Patient Reported Outcome (PRO) measures may better assess certain aspects of patient health and symptom domains. Thus, potentially supporting the future implementation of effective prehabilitation strategies. This study explores whether a PRO-based survey will identify the physical and emotional health and the social and financial status of patients newly diagnosed with MBC.

Conditions

Interventions

TypeNameDescription
OTHERGeneral health survey questionnairesPatient-reported outcome survey will be offered at baseline.
OTHERPROMIS Cancer Function Brief 3D profile questionnairesPatient-reported outcome survey will be offered at baseline.
OTHERFACT-G questionnairesPatient-reported outcome survey will be offered at baseline.
OTHERGodin Leisure-Time Exercise QuestionnairePatient-reported outcome survey will be offered at baseline.
OTHERREAP-S questionnairesPatient-reported outcome survey will be offered at baseline.

Timeline

Start date
2023-03-17
Primary completion
2024-02-05
Completion
2024-02-05
First posted
2023-03-06
Last updated
2024-04-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05755347. Inclusion in this directory is not an endorsement.